Don't miss our holiday offer - up to 50% OFF!
CJC1295 + DAC – 5mg (10 vials)
$185.00
CJC-1295 with DAC – 5mg – 10 Vials
CJC-1295 with DAC is a synthetic peptide studied for its interaction with growth hormone-releasing hormone (GHRH) receptors. Its Drug Affinity Complex (DAC) modification is designed to extend its circulation time. This listing describes a 5mg, 10-vial presentation. Confirm whether 5mg refers to each vial or the entire package, and verify the product’s identity and supplier documentation.
CJC-1295 with DAC – 5mg – 10 Vials
Product Overview
CJC-1295 with DAC is a synthetic peptide designed to interact with growth hormone-releasing hormone (GHRH) receptors. The DAC (Drug Affinity Complex) modification is intended to extend the peptide’s circulation time compared with shorter-acting forms.
The compound has been investigated in research relating to growth hormone regulation and endocrine signaling. Research findings should not be interpreted as proof of safety or effectiveness for general human use.
Product Details
- Product Name: CJC-1295 with DAC
- Listed Strength: 5mg
- Package Quantity: 10 vials
- Product Category: Synthetic Peptide
- Modification: Drug Affinity Complex (DAC)
- Research Area: GHRH receptor activity and growth hormone regulation
- Manufacturer: Confirm with supplier
- Formulation: Confirm with supplier
- Storage Requirements: Follow verified manufacturer documentation
Scientific Background
CJC-1295 with DAC has been studied for its interaction with GHRH receptors, which are involved in regulating growth hormone release from the pituitary gland.
The DAC modification is intended to increase the duration of circulation. This distinguishes it from shorter-acting CJC-1295 forms that do not contain DAC. The exact identity and formulation should be confirmed through reliable supplier documentation.
Product Verification
Before publishing or distributing this product, confirm:
- Whether 5mg refers to each vial or the entire package
- That the product is the DAC-modified form rather than a non-DAC variant
- Manufacturer identity and product labeling
- Batch identification and available quality documentation
- Storage and handling requirements
- Applicable regulatory status and distribution requirements
Important Safety and Regulatory Information
CJC-1295 with DAC is an investigational peptide and should not be represented as an approved treatment or as proven safe and effective for human use. Its safety profile and long-term effects are not sufficiently established for general therapeutic use.
This description is for product identification and research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Verify the product’s identity and regulatory status before publication.







Reviews
There are no reviews yet.